Arch Biopartners Inc (ARCH) - Total Assets

Latest as of December 2025: CA$25.03K CAD ≈ $18.11K USD

Based on the latest financial reports, Arch Biopartners Inc (ARCH) holds total assets worth CA$25.03K CAD (≈ $18.11K USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check Arch Biopartners Inc (ARCH) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Arch Biopartners Inc - Total Assets Trend (1997–2025)

This chart illustrates how Arch Biopartners Inc's total assets have evolved over time, based on quarterly financial data. Explore ARCH strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.

Arch Biopartners Inc - Asset Composition Analysis

Current Asset Composition (September 2025)

Arch Biopartners Inc's total assets of CA$25.03K consist of 100.0% current assets and 0.0% non-current assets.

Asset Category	Amount (CAD)	% of Total Assets
Cash & Equivalents	CA$0.00	2.0%
Accounts Receivable	CA$0.00	0.0%
Inventory	CA$0.00	0.0%
Property, Plant & Equipment	CA$0.00	0.0%
Intangible Assets	CA$0.00	0.0%
Goodwill	CA$0.00	0.0%

Asset Composition Trend (1997–2025)

This chart illustrates how Arch Biopartners Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see ARCH company net worth.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Arch Biopartners Inc's current assets represent 100.0% of total assets in 2025, an increase from 3.5% in 1997.
Cash Position: Cash and equivalents constituted 2.0% of total assets in 2025, up from 1.3% in 1997.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 11.0% in 1997.
Asset Diversification: The largest asset category is goodwill at 0.0% of total assets.

Arch Biopartners Inc Competitors by Total Assets

Key competitors of Arch Biopartners Inc based on total assets are shown below.

Company	Country	Total Assets
Xizang Haisco Pharmaceutical Group Co Ltd SHE:002653	China	CN¥7.21 Billion
Biomarin Pharmaceutical Inc NASDAQ:BMRN	USA	$7.59 Billion
Bachem Holding AG SW:BANB	Switzerland	CHF2.11 Billion
Asymchem Laboratories Tian Jin Co Ltd SHE:002821	China	CN¥20.70 Billion
ABL Bio Inc KQ:298380	Korea	₩280.93 Billion
Rapport Therapeutics, Inc. Common Stock NASDAQ:RAPP	USA	$497.60 Million
Ascletis Pharma Inc F:2VJ	Germany	€2.07 Billion
ABCELLERA BIOLOGICS F:8QQ	Germany	€1.36 Billion

Arch Biopartners Inc - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	0.01	0.11	0.13
Quick Ratio	0.01	0.11	0.13
Cash Ratio	0.00	0.00	0.00
Working Capital	CA$-3.60 Million	CA$-4.26 Million	CA$-2.32 Million

Arch Biopartners Inc - Advanced Valuation Insights

This section examines the relationship between Arch Biopartners Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	6211.54
Latest Market Cap to Assets Ratio	223.31
Asset Growth Rate (YoY)	-88.8%
Total Assets	CA$104.53K
Market Capitalization	$23.34 Million USD

Valuation Analysis

Premium Asset Valuation: The market values Arch Biopartners Inc's assets at a significant premium (223.31x), suggesting investors see substantial growth potential or unique competitive advantages.

Significant Asset Reduction: Arch Biopartners Inc's assets decreased by 88.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Arch Biopartners Inc (1997–2025)

The table below shows the annual total assets of Arch Biopartners Inc from 1997 to 2025.

Year	Total Assets	Change
2025-09-30	CA$104.53K ≈ $75.62K	-88.83%
2024-09-30	CA$935.62K ≈ $676.81K	-20.11%
2023-09-30	CA$1.17 Million ≈ $847.21K	+88.40%
2022-09-30	CA$621.64K ≈ $449.69K	-76.70%
2021-09-30	CA$2.67 Million ≈ $1.93 Million	+259.94%
2020-09-30	CA$741.30K ≈ $536.25K	+30.52%
2019-09-30	CA$567.98K ≈ $410.87K	-15.57%
2018-09-30	CA$672.69K ≈ $486.62K	+890.16%
2017-09-30	CA$67.94K ≈ $49.15K	-70.08%
2016-09-30	CA$227.03K ≈ $164.23K	-65.05%
2015-09-30	CA$649.50K ≈ $469.84K	+60.06%
2014-09-30	CA$405.79K ≈ $293.54K	+1001.91%
2013-09-30	CA$36.83K ≈ $26.64K	-60.75%
2012-09-30	CA$93.81K ≈ $67.86K	-57.75%
2011-09-30	CA$222.04K ≈ $160.62K	-58.52%
2010-09-30	CA$535.28K ≈ $387.22K	+33355.19%
2009-09-30	CA$1.60K ≈ $1.16K	-99.80%
2008-09-30	CA$797.32K ≈ $576.77K	-16.98%
2007-09-30	CA$960.41K ≈ $694.75K	+0.74%
2006-09-30	CA$953.38K ≈ $689.66K	-17.63%
2005-09-30	CA$1.16 Million ≈ $837.31K	-15.87%
2004-09-30	CA$1.38 Million ≈ $995.26K	-16.02%
2003-09-30	CA$1.64 Million ≈ $1.19 Million	+2668.41%
2002-09-30	CA$59.18K ≈ $42.81K	-16.12%
2001-09-30	CA$70.56K ≈ $51.04K	-97.02%
2000-09-30	CA$2.37 Million ≈ $1.71 Million	+87.01%
1999-09-30	CA$1.26 Million ≈ $914.95K	+575.79%
1998-09-30	CA$187.16K ≈ $135.39K	-47.71%
1997-09-30	CA$357.96K ≈ $258.94K	--

About Arch Biopartners Inc

V:ARCH Canada Biotechnology

Market Cap

$23.34 Million

CA$32.27 Million CAD

Market Cap Rank

#24574 Global

#950 in Canada

Share Price

CA$0.48

Change (1 day)

-3.06%

52-Week Range

CA$0.41 - CA$1.91

All Time High

CA$5.00